1-7 of 7
Marianne T Santaguida
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MDS and MDS/MPN Genomic Subgroups Demonstrate Differential E x Vivo Drug Sensitivity

Michael A Spinner, Steven A Schaffert, Henning Stehr, Marianne T Santaguida, Ryosuke Kita, Alexey Aleshin, James L Zehnder, Peter L. Greenberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4645.
https://doi.org/10.1182/blood-2021-152103
Published: 2021
Journal Articles

Prediction of Clinical Response to Venetoclax Plus Decitabine in AML Using a 7-Day Ex Vivo Assay

Markus D Lacher, Michelle A Richardson, Steven A Schaffert, Ryosuke Kita, Marianne T Santaguida, Erica K Anderson, Jordan Roselli, Wade Anderson, Arisa Paul, Christine Gu, Kathryn Vanderlaag, Zhihong Zeng, Abhishek Maiti, Courtney D. DiNardo, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 3464.
https://doi.org/10.1182/blood-2021-148891
Published: 2021
Journal Articles

Ex Vivo Drug Sensitivity Assay Correlates with Clinical Response and Identifies Panobinostat and Bortezomib As a Potential Novel Drug Combination for Pediatric AML

Debbie C Strachan, Christine Gu, Ryosuke Kita, Michelle A Richardson, Erica K Anderson, Alan K Gonzalez, Noah J Keogh, Hailey H Oviedo, Michelle C Alozie, Raushan Rashid, Maci Terrell, Andrea N Marcogliese, Marianne T Santaguida, Alexandra McLean Stevens
Journal: Blood
Blood (2021) 138 (Supplement 1): 2361.
https://doi.org/10.1182/blood-2021-145275
Published: 2021
Journal Articles

Correlating Clinical and Genomic Features with E x Vivo Drug Sensitivity in Patients with Myelodysplastic Syndromes and Related Myeloid Neoplasms

Michael A Spinner, MD, Steven A Schaffert, PhD, Alexey Aleshin, MD MBA, Marianne T Santaguida, PhD, Hiroomi Tada, MDPhD, Peter L. Greenberg
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140095
Published: 2020
Journal Articles

Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options — a COG and Target Pediatric AML Study

Jenny L. Smith, MSc, MD, Rhonda E. Ries, MA, Marianne T. Santaguida, BSc, PhD, Christos Gekas, PhD, Todd A Alonzo, PhD, Robert B Gerbing, MA, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Tiffany Hylkema, BS, Lisa Eidenschink Brodersen, PhD, Michael R. Loken, PhD, Hamid Bolouri, PhD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 881.
https://doi.org/10.1182/blood-2018-99-115544
Published: 2018
Journal Articles

PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells

Liangxian Cao, MD, Arthur Branstrom, PhD, John Baird, PhD, Christopher Trotta, PhD, Joseph Colacino, PhD, Marianne T. Santaguida, BSc, PhD, Diane Heiser, PhD BA, Mark Ma, PhD, Kensuke Kojima, MD PhD, Stuart Peltz, PhD, Edward O'Mara, MD, Robert Spiegel, MD, Marla Weetall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1371.
https://doi.org/10.1182/blood.V130.Suppl_1.1371.1371
Published: 2017
Journal Articles

JunB Limits Hematopoietic Stem Cell (HSC) Functions as a Protective Mechanism against Initiation of Myeloid Malignancy

Marianne T Santaguida, PhD, Koen Schepers, PhD, Bryan C King, Emmanuelle Passegue, PhD
Journal: Blood
Blood (2008) 112 (11): 1358.
https://doi.org/10.1182/blood.V112.11.1358.1358
Published: 2008